PXRB (PixarBio) Accumulated other comprehensive income (loss) : $0.00 Mil (As of Sep. 2016)

View and export this data going back to 2016. Start your Free Trial

What is PixarBio Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. PixarBio's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2016 was $0.00 Mil.

PixarBio Accumulated other comprehensive income (loss) Historical Data

The historical data trend for PixarBio's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio Accumulated other comprehensive income (loss) Chart

PixarBio Annual Data

Trend

Dec14

Dec15

Accumulated other comprehensive income (loss)

PixarBio Quarterly Data
	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial					-	-	-	-	-

PixarBio Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

PixarBio Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of PixarBio's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

PixarBio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155

Website

https://www.pixarbio.com

PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.